Skip to main content
SpringerLink
Log in

Somatomedin-1 Shows Promise in Metabolic Disorders

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Laron Z. Drugs 45: 1–8, 1993

    Article  CAS  PubMed  Google Scholar 

  2. Guler HP, et al. Acta Endocrinol 121: 753–758, 1989

    CAS  PubMed  Google Scholar 

  3. Laron Z, et al. Lancet 339: 1258–1261, 1992

    Article  CAS  PubMed  Google Scholar 

  4. Usala A-L, et al. N Engl J Med 327: 853–857, 1992

    Article  CAS  PubMed  Google Scholar 

  5. Schalch DS, et al. In Modem concepts of insulin like growth factors, pp. 705–713, Elsevier, New York-Amsterdam, 1991

    Google Scholar 

  6. Haffner SM, et al. Diabetes 41: 715–722, 1992

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Somatomedin-1 Shows Promise in Metabolic Disorders. Drugs Ther. Perspect 2, 6–7 (1993). https://doi.org/10.2165/00042310-199302010-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199302010-00003

Keywords

Search

Navigation